Research Faculty

Address
630 W 168th St
P&S 12-440
New York, NY, 10032


Phone: 212-305-8973
Fax: 212-342-0119

nm2631@cumc.columbia.edu
Education and Training
B.A. Hunter College of CUNY, NY, 2004
M.A. Hunter College of CUNY, NY, 2005
M.Sc. Weill Cornell Medical College, NY, 2011
Ph.D. The Graduate Center, CUNY, NY, 2011



Affiliation
Taub Institute



Collaborations
Karen Duff
Catherine Clelland

Natura Myeku , Ph.D.
Assistant Professor of Pathology and Cell Biology
Research Summary

Our laboratory has a long-standing interest in understanding the mechanism of deficient protein quality control in tauopathy disorders that have a common feature - accumulation of pathological tau. In particular, we are interested in studying the ubiquitin proteasome system (UPS), which is the principal pathway for protein turnover in eukaryotic cells. Degradation of proteins via the UPS involves two discrete and successive steps: tagging of the substrate protein covalently by poly-ubiquitin chain and the subsequent degradation of the tagged protein by the 26S proteasome, composed of the 20S catalytic core and the19S regulatory particle. As we age the function of 26S proteasomes in neurons become less efficient, but in Alzheimer’s disease and many neurodegenerative diseases, proteasome function becomes profoundly impaired contributing to accumulation of oligomers and aggregates, which is a common pathological hallmark of these, otherwise clinically and etiologically diverse diseases. We are using unique transgenic mouse models of 26S proteasome and tauopathy to identify mechanisms associated with dysregulated clearance of tau and disease progression.

Another major focus of our research is translating our knowledge of the UPS biology into novel therapeutic approaches for treatment of Alzheimer’s disease and possibly other proteotoxic diseases.

Our lab has demonstrated that phosphorylation of 26S proteasomes, by clinically relevant drugs, can lead to activated proteasome proteolysis, resulting in decreased insoluble tau levels, attenuated tauopathy and rescued cognitive performance (Myeku et al. 2016). And current in vivo projects are underway to identify pathways for on-target, locally restricted proteasome activation in neurons where misfolded proteins accumulate first in early stages of Alzheimer’s.

My overarching goal is to continue my research to understanding proteinopathy-induced diseases and their relationship with protein quality control in the cell. Utilizing my current expertise in clearance machinery, transgenic mouse models and with a background in translational research, I plan to fully devote my career to translational science, where new discoveries can hopefully be translated swiftly into new therapies for neurodegenerative diseases, many of which are currently incurable.

Selected Publications

Myeku N, Clelland CL, Ermani S., Kukushkin NV, Figueroa HY, Yu HW, Goldberg AL and Duff KE. “Tau- driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by
activating cAMP-PKA signaling”. Nat Med. 2016 Jan;22(1):46-53. PMID: 26692334.

Myeku N, Wang H, Figueiredo-Pereira ME. (2012) “cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons” Neurosci Lett. 2012 Oct 11;527(2):126-31: PMID: 22982149

Myeku N and Figueiredo-Pereira ME. “Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: its association with sequestosome 1/p62.” J. Biol. Chem. 2011; 286(25):22426-40. PMID:21913107

Myeku N., Metcalfe MJ, Huang Q, and Figueiredo-Pereira ME. “Assessing proteasome impairment and the accumulation/aggregation of ubiquitinated proteins in neuronal cultures.” Methods Mol Biol. 2011; 793:273-96. PMID:21913107

Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS, Gestwicki JE, Dickey CA, Yu WH, Duff K. “Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo.” Autophagy. 2012, Apr 1;8(4): PMID:22361619

Myeku N and Figueiredo-Pereira ME. (2009) “Ubiquitin/Proteasome and Autophagy/Lysosome Pathways: Comparison and Role in Neurodegeneration.” Handbook of Neurochemistry and Molecular Neurobiology, pp. 513-528; Ed. Lajtha, Banik and Ray; Pub. Springer US.

Arnaud LT, Myeku N, Figueiredo-Pereira ME. “Proteasome–caspase–cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.” J. Neurochem. 2009;110(1):328-42. PMID:19457109


top
 
 
Contact the Pathology Webmaster at PathWebMaster@columbia.edu